Not logged in Share Save
Share Save
Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy Kunimatsu, Yusuke; Nishioka, Naoya; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Ishida, Masaki; Kijima, Takashi; Takayama, Koichi Share Save
Share Save
Share Save
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression Sasada, Aosa; Kawachi, Hayato; Yamada, Tadaaki; Hata, Tae; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Okada, Asuka; Chihara, Yusuke; Kijima, Takashi; Takayama, Koichi Share Save
Share Save
Share Save
Share Save
Epidemiology and clinical course of large cell neuroendocrine carcinoma of the lung: The Japanese lung cancer registry study Shirai, Yukina; Shukuya, Takehito; Asao, Tetsuhiko; Takahashi, Kazuhisa; Shintani, Yasushi; Sekine, Ikuo; Takayama, Koichi; Inoue, Akira; Okamoto, Isamu; Kawaguchi, Tomoya; Yamamoto, Nobuyuki; Miyaoka, Etsuo; Yoshino, Ichiro; Date, Hiroshi Share Save
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Shimose, Takayuki; Takayama, Koichi Share Save
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients Morita, Midori; Tsunashima, Ryo; Yoshinami, Tetsuhiro; Ishida, Masaki; Iwasaku, Masahiro; Kitano, Sae; Kato, Chikage; Sakaguchi, Koichi; Takayama, Koichi; Naoi, Yasuto Share Save
Immunological characteristics of bronchoalveolar lavage fluid and blood across connective tissue disease-associated interstitial lung diseases Hirano, Aiko; Sakashita, Aki; Fujii, Wataru; Bassler, Kevin; Tsuji, Taisuke; Kadoya, Masatoshi; Omoto, Atsushi; Hiraoka, Noriya; Imabayashi, Tatsuya; Kaneko, Yoshiko; Sofue, Hideaki; Maehara, Yosuke; Seno, Takahiro; Wada, Makoto; Kohno, Masataka; Fukuda, Wataru; Yamada, Kei; Takayama, Koichi; Kawahito, Yutaka Share Save
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1%to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study Nishioka, Naoya; Hata, Tae; Yamada, Tadaaki; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Hibino, Makoto; Okada, Asuka; Chihara, Yusuke; Kawachi, Hayato; Kijima, Takashi; Takayama, Koichi Share Save
Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study Nishioka, Naoya; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Masui, Taiki; Sai, Natsuki; Ishida, Masaki; Katayama, Yuki; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi Share Save
Share Save
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Cancer Database Okuma, Yusuke; Shintani, Yasushi; Sekine, Ikuo; Shukuya, Takehito; Takayama, Koichi; Inoue, Akira; Okamoto, Isamu; Kiura, Katsuyuki; Yamamoto, Nobuyuki; Kawaguchi, Tomoya; Miyaoka, Etsuo; Yoshino, Ichiro; Date, Hiroshi Share Save
Share Save
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019 Yamamoto, Chie; Taniguchi, Masashi; Furukawa, Keitaro; Inaba, Toru; Niiyama, Yui; Ide, Daisuke; Mizutani, Shinsuke; Kuroda, Junya; Tanino, Yoko; Nishioka, Keisuke; Watanabe, Yohei; Takayama, Koichi; Nakaya, Takaaki; Nukui, Yoko Share Save
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells Morimoto, Kenji; Yamada, Tadaaki; Hirai, Soichi; Katayama, Yuki; Fukui, Sarina; Sawada, Ryo; Tachibana, Yusuke; Matsui, Yohei; Nakamura, Ryota; Ishida, Masaki; Kawachi, Hayato; Kunimasa, Kei; Sasaki, Takaaki; Nishida, Makoto; Furuya, Naoki; Watanabe, Satoshi; Shiotsu, Shinsuke; Nishioka, Naoya; Horinaka, Mano; Sakai, Toshiyuki; Uehara, Hisanori; Yano, Seiji; Son, Bo-Kyung; Tokuda, Shinsaku; Takayama, Koichi Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
